Find clinical trials for Triple Negative Breast Cancer in Salt Lake City, UT

oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...

escalation will be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....

activity of GEN1107 (PRO1107) in participants with advanced solid tumors. This study consists of 2 parts, Part A: dose escalation and dose l...

This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...